The Efficacy of a Frequency-tuned Electromagnetic Field Treatment in Facilitating the Recovery of Subacute Ischemic Stroke Patients - a Pivotal Study (THE EMAGINE STUDY) (BQ5)
Sponsor: BrainQ Technologies Ltd.
A NA clinical study on Ischemic Stroke, this trial is completed. The trial is conducted by BrainQ Technologies Ltd. and has accumulated 10 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
10 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Apr 2024 — Jul 2024 [monthly]
Completed NA
Status: Recruiting → Completed
-
Mar 2023 — Apr 2024 [monthly]
Recruiting NA
▶ Show 5 earlier versions
-
Feb 2023 — Mar 2023 [monthly]
Recruiting NA
-
Sep 2022 — Feb 2023 [monthly]
Recruiting NA
-
Jan 2022 — Sep 2022 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Nov 2021 — Jan 2022 [monthly]
Not Yet Recruiting NA
-
Oct 2021 — Nov 2021 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- BrainQ Technologies Ltd.
For direct contact, visit the study record on ClinicalTrials.gov .